España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Enfusion
ENFN
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$11.07
0.11
1.00%
At close: -
$11.07
0.00
0.00%
After Hours: 5:41 PM EDT
Get Report
Comment
Enfusion (ENFN) announced it will be merged with Clearwater Analytics Hldg (CWAN) on Monday, January 13, 2025 for $1.5B paid in cash & stock
Enfusion (ENFN) Forecast
News
Earnings
Enfusion (ENFN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Enfusion (NYSE:ENFN) Stock
Enfusion Stock (NYSE: ENFN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 17, 2025
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, January 13, 2025
William Blair Downgrades Enfusion to Market P...
Benzinga Newsdesk
Clearwater Analytics to Acquire Enfusion for ...
Benzinga Newsdesk
Thursday, January 02, 2025
This Analyst With 85% Accuracy Rate Sees Around 10% Upside In Alphabet - Here Are 5 Stock Picks For 2024 From Wall Street's Most Accurate Analysts
Avi Kapoor
Monday, December 30, 2024
This Analyst With 82% Accuracy Rate Sees Around 28% Upside In Apple - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
Avi Kapoor
Friday, December 27, 2024
Sell Alert: Bradley Herring Cashes Out $259K In Enfusion Stock
Benzinga Insights
Monday, December 23, 2024
Piper Sandler Maintains Neutral on Enfusion, ...
Benzinga Newsdesk
Thursday, December 19, 2024
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, December 18, 2024
Stifel Maintains Buy on Enfusion, Raises Pric...
Benzinga Newsdesk
Tuesday, December 03, 2024
Neal Pawar Executes Sell Order: Offloads $190K In Enfusion Stock
Benzinga Insights
Monday, November 04, 2024
Enfusion Narrows FY2024 Sales Guidance from $...
Benzinga Newsdesk
Enfusion Q3 Adj $0.05 Misses $0.06 Estimate, ...
Benzinga Newsdesk
Friday, September 20, 2024
Enfusion shares are trading higher after the ...
Benzinga Newsdesk
Enfusion Is Interviewing Investment Banks To ...
Benzinga Newsdesk
Tuesday, August 06, 2024
Enfusion Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks
Enfusion Continues To Expect FY24 GAAP Revenu...
Benzinga Newsdesk
Enfusion Q2 2024 Adj. EPS $0.05 Misses $0.06 ...
Benzinga Newsdesk
Thursday, May 09, 2024
Enfusion Q1 2024 Adj EPS $0.06 Beats $0.04 Es...
Benzinga Newsdesk
Thursday, March 14, 2024
Watching Enfusion; Spruce Point Capital Manag...
Benzinga Newsdesk
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, March 13, 2024
A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts
Benzinga Insights
B of A Securities Maintains Underperform on E...
Benzinga Newsdesk
Tuesday, March 12, 2024
Enfusion shares are trading higher after the ...
Benzinga Newsdesk
Enfusion Expects 2024 Revenue of $200M-$210M ...
Benzinga Newsdesk
Enfusion Q4 2023 Adj EPS $0.04 Misses $0.05 E...
Benzinga Newsdesk
Earnings Scheduled For March 12, 2024
Benzinga Insights
Monday, March 11, 2024
Earnings Outlook For Enfusion
Benzinga Insights
Wednesday, March 06, 2024
Major Purchase Alert: Oleg Movchan Invests $120K In Enfusion Stock
Benzinga Insights
Wednesday, February 28, 2024
Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock
Anusuya Lahiri
Goldman Sachs Downgrades Enfusion to Sell, Lo...
Benzinga Newsdesk
Tuesday, January 30, 2024
JP Morgan Downgrades Enfusion: Here's What You Need To Know
Benzinga Insights
Enfusion shares are trading lower after JP Mo...
Benzinga Newsdesk
JP Morgan Downgrades Enfusion to Underweight,...
Benzinga Newsdesk
Tuesday, January 02, 2024
This Analyst With 84% Accuracy Rate Sees Around 13% Upside In Darden Restaurants - Here Are 5 Stock Picks For 2023 From Wall Street's Most Accurate Analysts
Avi Kapoor
Wednesday, December 20, 2023
Piper Sandler Maintains Neutral on Enfusion, ...
Benzinga Newsdesk
Tuesday, December 19, 2023
Enfusion Chief Executive Officer Trades $1.00M In Company Stock
Benzinga Insights
Wednesday, December 06, 2023
Insider Unloading: Oleg Movchan Sells $1.51M Worth Of Enfusion Shares
Benzinga Insights
Wednesday, November 29, 2023
Massive Insider Trade At Enfusion
Benzinga Insights
Monday, November 20, 2023
Enfusion Announces Appointment Of Neal Pawar ...
Benzinga Newsdesk
Tuesday, November 07, 2023
UBS Initiates Coverage On Enfusion with Neutr...
Benzinga Newsdesk
Enfusion Q3 EPS $0.02 Misses $0.05 Estimate, ...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Wednesday, August 09, 2023
Goldman Sachs Maintains Neutral on Enfusion, ...
Benzinga Newsdesk
Morgan Stanley Maintains Overweight on Enfusi...
Benzinga Newsdesk
Tuesday, August 08, 2023
Enfusion shares are trading lower after the c...
Benzinga Newsdesk
Enfusion Sees FY23 Revenue $170M-$175M Vs $18...
Benzinga Newsdesk
Enfusion Q2 EPS $0.01 Misses $0.05 Estimate, ...
Benzinga Newsdesk
Earnings Scheduled For August 8, 2023
Benzinga Insights
Monday, August 07, 2023
Earnings Preview: Enfusion
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
